By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Exact Sciences today said that it has raised net proceeds of $27.1 million in a public offering of common stock.

The company sold a total of 3,593,750 shares of its common stock at $8 per share. The underwriters on the offering exercised their over-allotment option in full, Exact Sciences said.

RW Baird acted as sole book-running manager in the offering. William Blair was co-manager.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.